Condition: Rectal Cancer · Sponsor: Maastricht Radiation Oncology
The aim of the study is to provide prospective data regarding microscopic tumor spread in all directions from the macroscopic tumor in pathology specimens, as seen by eye, and on imaging to define the target volume for endoluminal radiation boosting in rectal cancer patients.
This description comes directly from the study's public registry record.
Maaike Berbée, MD, PhD · 0031884455600 · maaike.berbee@maastro.nl
Evert Van Limbergen, MD, PhD · 0031884455600 · evert.vanlimbergen@maastro.nl
Always discuss trial participation with your own doctor first.
| Maastro | Maastricht, Limburg, Netherlands | Recruiting |
| Maastricht University Medical Center | Maastricht, Limburg, Netherlands | Recruiting |
| Catharina Hospital | Eindhoven, North Brabant, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04927897